# Gadopiclenol in Contrast Enhanced MRI of the Prostate

> **NCT06226129** · PHASE4 · RECRUITING · sponsor: **Columbia University** · enrollment: 150 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Gadopiclenol

## Key facts

- **NCT ID:** NCT06226129
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-14
- **Primary completion:** 2027-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06226129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06226129, "Gadopiclenol in Contrast Enhanced MRI of the Prostate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06226129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*